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Abstract
Purpose: The accurate prediction of stray neutron dose has become increasingly important as it
increases the risk of second cancer development after proton therapy. Previously reported analytical models predicted the quantity dose equivalent, which includes physical and biological considerations but does not explicitly take into account material dependence and variation in the radiation quality. The purpose of this study was to investigate the feasibility of an analytical model
of absorbed dose to water from stray neutrons in proton therapy.
Methods: To calculate neutron absorbed dose and kerma in water, the authors developed analytical models of neutron spectral fluence and kerma coefficients, used neutron spectral fluence and
absorbed dose data from Monte Carlo simulations, and evaluated neutron kerma coefficients
from the literature.
Results: The analytical model predictions of absorbed dose to water agreed relatively well with
that from Monte Carlo simulations. On average, the percentage difference between the analytical
model and Monte Carlo simulations was 49 percent for absorbed dose to water for the proton
beam energies ranging from 120 MeV to 250 MeV.
Conclusion: The results suggest that it is feasible to analytically model absorbed dose to water
from stray neutrons with good accuracy. A potentially important advantage of this fluence-based
approach is that it provides the ability to take material dependence into account and helps with
characterization of radiation quality.
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Chapter 1. Introduction
Cancer is one of the most significant health issue in the developed world. Approximately
one in two men and women will be diagnosed with some form of cancer in their lifetime
(Howlader et al. 2014). With advancements in cancer care the 5-year survival rate is now 83%
averaged overall for all cancers (Siegel et al. 2018) and the number of cancer survivors in United
States is expected to increase from 15.5 million in 2016 to 20.3 million by 2026 (DeSantis et al.
2014, Siegel et al. 2018). Nearly two thirds of all cancer patients will receive radiation therapy at
some point during their treatment (Smart 2010).
Radiation-induced late effects, such as cardiac toxicity, second cancers, and fertility complications, are prevalent in these cancer survivors (NRC 2006, NCRP 2011, Williams et al.
2018). With increasing survival, it has become essential to understand the mechanism behind
these complications in an attempt to mitigate against them and improve the quality of life for
cancer survivors.
Childhood cancer survivors who received radiation therapy are at elevated risk for health
complications, with a 2.5 times increased risk of developing a second cancer when compared to
their healthy siblings (Tukenova et al. 2010). Modern radiation therapy techniques, such as proton therapy, seek to avoid radiation side effects by delivering a highly conformal dose to the tumor. However, normal tissues outside the treatment field are unavoidably exposed to considerable levels of scattered and leakage radiation (Figure 1.1). Most secondary malignancies in adults
occur outside the primary field (Doerr et al. 2002, Diallo et al. 2009) implicating stray radiation
exposures. Therefore, accurate prediction of stray dose will become increasingly important for
understanding and avoiding radiogenic second cancers.
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Figure 1.1. Schematic diagram representing a treatment head and patient treated. Therapeutic radiation beam is shown in red while blue represents stray radiation incident upon patient's whole
body (Newhauser et al. 2011).

Proton therapy provides uniform target coverage and lower dose to normal tissue than
photon therapy. However, patients undergoing proton therapy still receive stray radiation dose,
primarily from neutrons that are generated in treatment head and the patient’s body (Figure 1.1).
These neutrons are created through various physical processes such as direct reactions, pre-compound emission, compound emission, etc. Theoretically the risk of secondary cancer after proton
therapy is significantly lower than that after photon therapy, but epidemiologic evidence is lacking.
Measurements of the neutron fields generated during proton therapy have provided critical insights. Yan et al. (2002) measured the neutron dose equivalent outside the treatment field
and demonstrated the existence of a neutron bath from three proton-therapy beamlines. Since
then, numerous researchers have reported measurements of secondary neutron dose for a proton-
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therapy beamline, which were selectively reviewed in NCRP (2011). Tayama et al. (2006) validated Monte-Carlo codes using measurements of neutron yield for various proton energies.
Measurements are essential for developing (Schneider et al. 2015) and validating (Farah et al.
2015) analytical models of both therapeutic and stray dose. Recently myriad measurement-based
studies has been published for pencil beam scanning (Islam et al. 2017, Trinkl et al. 2017) as
well as passive-scattering (Howell et al. 2016, De Smet et al. 2017) proton beamlines. Measurements are technically challenging and time consuming.
Monte Carlo simulations allow researchers to determine in-field and out-of-field neutron
dose for arbitrary geometries and treatment modalities. Though extremely insightful, the long
computation times and complexity of MC simulations has limited its application to research settings. Agosteo et al. (1998) first utilized MC methods to simulate dose from secondary neutrons
and photons from an ocular proton treatment. In addition to the quantities provided by basic
measurements, it is possible to determine and discriminate the source of the particles, which can
be used to develop analytical models. These advantages led to increasing literature of neutron exposure simulated with MC techniques (Newhauser et al. 2002, Hongyu et al. 2005, Zheng et al.
2008, Perez-Andujar et al. 2013, Zhang et al. 2013). This approach has been applied to both active scanning (Trinkl et al. 2017) and passive (Farah et al. 2015, Bonfrate et al. 2016) beamlines.
Data generated by MC are being used for the training and validation of analytical models.
To develop methods suitable for routine clinical calculations of absorbed dose, several
research groups have proposed analytical models. An early attempt to analytically model neutron
dose was reported by Polf et al. (2005). Anferov (2010) proposed an analytical model for converting proton beam losses into secondary-neutron dose. Newhauser et al. (2017) presented a
concise review of recent analytical models and their efficacy and concluded that these may offer
3

faster computations of equivalent dose with acceptable accuracy. Another such model has been
developed by Newhauser and co-workers over the past decade. It is nonproprietary and straightforward to implement. Basic versions of these analytical models were developed between 2006
and 2010 at The University of Texas MD Anderson Cancer Center (Zhang et al. 2010) and advanced versions between 2011 and 2017 at Louisiana State University with collaborators from
Mary Bird Perkins Cancer Center and other institutions (Perez-Andujar et al. 2013, Eley et al.
2015, Farah et al. 2015, Schneider et al. 2015). This model estimates equivalent dose per prescribed proton absorbed dose in water phantom. The recent version reported by Schneider et al.
(2015) was simpler to configure and use than previously version and offered continuous applicability from 100-250 MeV in proton beam energy. Eley et al. (2015) integrated this model into a
treatment planning system and extended the model to include range modulation and arbitrary
collimator shapes. Gallagher et al. (2018) performed an independent application and evaluation
of this model in clinically realistic circumstances and demonstrated that analytical models may
be useful for clinicians and researchers to calculate equivalent dose. As explained, previous models have predicted the quantity dose equivalent, which was developed for radiation protection
purposes and includes an amalgamation of physical and biological considerations. However, this
approach is limited in that it does not take into account material dependence (e.g., muscle versus
bone) and does not allow characterization of radiation quality.
The objective of this study was to investigate the feasibility of an analytical model of absorbed dose to water from stray neutrons in proton therapy. The model calculates neutron spectral fluence, kerma coefficients, kerma, absorbed dose, and mean neutron energy.
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Chapter 2. Methods and Materials
2.1 Kerma and Absorbed Dose
The interactions of neutrons in matter depends upon their energy and material composition. Low energy neutrons in tissue mostly undergo neutron capture by nitrogen or hydrogen
whereas intermediate and fast neutrons mostly interact through elastic scattering on hydrogen nuclei. Very fast neutrons can undergo non-elastic nuclear reactions with a nucleus or one or more
nucleons in a nucleus.
The kerma (𝐾) for neutrons is given by

𝐾=

d𝜖tr
d𝑚

(1)

where d𝜖𝑡𝑟 is the mean sum of the initial kinetic energy of all the charged particles liberated in
the mass d𝑚 of a material by the neutrons incident on d𝑚.
Due to radiative losses and escaping charged particles, not all of the energy is deposited
locally, i.e., at the incident neutron’s original point of interaction. The absorbed dose (𝐷) is
given by

𝐷=

d𝜖
d𝑚

(2)

where d𝜖 is the expectation value of energy imparted to matter of mass d𝑚.
Kerma and absorbed dose are related. The value of the kerma approaches that of the absorbed dose to the degree that charged particle equilibrium (CPE) exists, that radiative losses are
negligible. CPE exists at a point if charged-particle fluence rate, differential in energy and direction, is constant within distances equal to the maximum charged-particle range (ICRU 2000,
5

ICRU 2014). Under conditions of CPE each charged particle of a given type and energy leaving
the volume is replaced by identical particle of same energy entering in-terms of their expectation
values, i.e.,
CPE

(3)

CPE

(4)

𝜖tr = 𝜖
Thus, the absorbed dose is equal to kerma, or
𝐷 = 𝐾
In polyenergetic fields kerma is,
𝐸n,max

Φ(𝐸n ) 𝑘ϕ (𝐸n ) d𝐸n

𝐾= ∫

(5)

0

where Φ(𝐸n ) is the neutron spectral fluence, 𝑘ϕ (𝐸n ) is kerma coefficient and 𝐸n is neutron energy. Thus, substituting Equation (4) in Equation (5), we have
CPE

𝐸n,max

𝐷 = 𝐾= ∫

Φ(𝐸n ) 𝑘ϕ (𝐸n ) d𝐸n

(6)

0

This expression is very useful because with knowledge of the neutron spectral fluence and kerma
coefficients, we can calculate kerma and, under condition of CPE, the absorbed dose.

2.2 Model for Kerma Coefficient
The kerma coefficient, 𝑘ϕ (𝐸n ), or fluence-to-kerma conversion coefficient, is the quotient of the kerma at a given point in a material by the fluence of uncharged ionizing particles, Φ,
at the same point, or

𝑘ϕ =

6

𝐾
𝛷

(7)

The kerma coefficient may also be calculated from the microscopic cross sections according to
prod

𝑘ϕ (𝐸n ) = ∑ 𝑁j ∑ 𝜖̅ij (𝐸n ) 𝜎ij
j

(8)

(𝐸n )

𝑖

where 𝑁j denotes the number of target nuclides of type j per unit mass in the material, 𝜖̅ij the avprod

erage energy transferred to kinetic energy of charged particles of type i, and 𝜎ij

(𝐸n ) the total

production cross section for a charged particle of type i.
Neutron kerma coefficients are well known below 20 MeV and, with larger uncertainties,
between 20 MeV and 150 MeV. At higher neutron energies, information on microscopic cross
sections and evaluated kerma coefficient is uncertain and incomplete (ICRU 2000).
2.2.1 Analytical Model of Neutron Kerma Coefficient
In this study we propose the following piecewise formula for neutron kerma coefficients

𝑘ϕ (𝐸n ) = 𝑎1 cosh(Log(𝐸n )) + 𝛨(𝐸n,Thresh − 𝐸n )

𝑏1
√2𝜋𝜎1 ′

𝑒

(

−(Log(𝐸n )−𝜇1 )2
)
2𝜎′21

(9)

+ 𝛨(𝐸n − 𝐸n,Thresh ) (𝑢 𝐸n 2 + 𝑣)
where H is the Heaviside function, 𝐸n is neutron energy, and 𝐸n,Thresh is the neutron threshold
energy that determines the energy interval covered by each of the two higher energy terms.
𝑎1 , 𝑏1 , 𝜎1 ′ , 𝜇1 , 𝑢 and 𝑣 are empirical parameters whose values are obtained by fitting Equation
(9) to tabulated kerma coefficient data. Equation (9) uses a hyperbolic cosine function for thermal regions, log-normal distribution below 𝐸n,Thresh and second order polynomial to model
kerma coefficient at higher energies.
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2.2.2 Kerma Coefficient Data for Fitting
We fitted Equation (9) to evaluated kerma coefficient data from ICRU (2000) (ICRU Report 63). The models and experimental data used to derive the evaluated data tables were described by the ICRU (2000). We fitted kerma coefficient data for water, bone, air, muscle, TEMethane, TE-Propane, A150 tissue substitute plastic, over the interval of 2.53 × 10−8 MeV to
150 MeV neutron energy.
2.2.2 Fitting Procedure
Fitting was performed using a non-linear least squares method and trust-region algorithm
implemented in commercial software (MATLAB® and Curve Fitting Toolbox 3.5.6, 2017b, The
MathWorks Inc., Natick, Massachusetts, United States). To assess goodness of fit, average and
maximum differences between analytical model and evaluated kerma coefficient data were reported.

2.3 Analytical Model for Neutron Spectral Fluence
2.3.1 Analytical Model
Neutrons emitted during proton therapy span about twelve decades of energy. Following
the approach from our group (Perez-Andujar et al. 2013, Schneider et al. 2015), we subdivided
the spectra into four neutron energy regimes (intranuclear cascade, evaporation, 1⁄𝐸 and thern

mal), as shown in Figure 2.1.
A fast proton may penetrate the coulomb barrier of an atomic nucleus. Once inside, it
may interact directly with one or a few nucleons, resulting in their emission, usually in the cone
of the forward direction due to the principle of conservation of energy. These are called cascade
neutrons or direct neutrons. The incident proton may interact with many nucleons in the nucleus,
8

thus sharing the kinetic energy amongst them. As this process of sharing proceeds, the energy is
statistically distributed, eventually reaching an equilibrium where the nucleus is in an excited
state. After equilibration, the compound nucleus comprises the original nucleus and the incident
proton. The nucleus can de-excite by evaporating off one or more of its nucleons, in a manner
that is analogous to the evaporation of water, which is sometimes called compound emission.
Nucleons may be emitted during the equilibration process, which is called pre-equilibrium emission. The third energy regime, 1⁄𝐸 neutrons, correspond to neutrons that have lost some portion
n

of their energy via inelastic scattering, a process referred to as moderation. A small proportion of
these neutrons will be lost via capture processes. Finally, the lowest energy regime corresponds
to moderated neutrons that have lost most of their kinetic energy and are in thermal equilibrium
with the environment. These undergo elastic scattering until they are eventually captured, e.g. by
hydrogen and nitrogen nuclei in the material. The emission of evaporation neutrons, 1⁄𝐸 neun

trons and thermal neutrons is isotropic in nature due to loss of directionality information during
the equilibration process.
The analytical model for neutron spectral fluence at any point 𝑝(𝑥, 𝑦, 𝑧) in a water phantom is given by
4

(10)

Φ(𝐸n ) = 𝐹𝐸p 𝐹Div ∑[𝐴𝐹i 𝑂𝐴𝐹i ϕi (𝐸n )]
𝑖=1

where 𝐹𝐸p is proton energy scaling factor that characterizes the dependence of magnitude of
neutron fluence on proton beam energy and is given by,

9

Figure 2.1. Neutron energy fluence spectrum from proton therapy illustrating contributions from
separate energy regimes.

𝜉

𝐹𝐸p = 𝛼E

𝐸p
(
)
𝐸p,ref

(11)

where 𝛼E is a constant and 𝜉 is an exponent governing the power law dependence in proton energy, 𝐸p is proton energy and, 𝐸p,ref is a reference proton energy. Both 𝛼E and 𝜉 are empirical fit
parameters. In this work, 𝐸p,ref was 120 MeV. In this work, spectral fluence and fluence are normalized per proton entering the treatment head.
𝐹Div denotes the neutron fluence-divergence factor, or

𝐹Div

𝑑 −𝜏
=[
]
𝑑iso

10

(12)

where 𝑑 is distance from the effective neutron source to calculation point 𝑝(𝑥, 𝑦, 𝑧) (Figure 2.2),
𝑑iso is the distance from the effective neutron source to isocenter (Figure 2.2), and the exponent
𝜏 governs the rate of divergence of the source.
The effective attenuation factor (𝐴𝐹i ) of neutrons in water is given by
𝐴𝐹i = 𝑒 −𝛼i[𝑑

′ −𝑑 ′ ]
iso

(13)

′
where 𝛼i is the effective attenuation coefficients for the 𝑖 th neutron energy regime, 𝑑iso
is the

distance from phantom surface to the isocenter (Figure 2.2), and 𝑑 ′ is the distance from the surface to the calculation point along the ray (Figure 2.2).
The off-axis factor (𝑂𝐴𝐹i ) describes the lateral distribution of neutron fluence and is
given by the normalized gaussian
−[
(𝑑iso )2
𝑂𝐴𝐹i =
𝑒
2𝜋 (𝜎i 𝑧)2

2
(𝑥 2 +𝑦 2 )𝑑iso
]
2
2
2𝜎i 𝑧

(14)

where, 𝜎i is the gaussian width parameter of the 𝑖 th neutron energy regime. The gaussian width
𝜎𝑧

parameter after variable transformation in Equation (14), (𝑑 i ) scales with depth 𝑧 to take into
iso

account geometric magnification.
Finally, ϕi (𝐸n ), represents the contribution of spectral fluence to a point in the phantom
from 𝑖 th neutron regime, where ϕ1 (𝐸n ) denotes the contribution from thermal neutrons, ϕ2 (𝐸n )
denotes the contribution from 1⁄𝐸 neutrons, ϕ3 (𝐸n ) denotes the contribution from evaporation
n

neutrons, and ϕ4 (𝐸n ) denotes the contributions from high-energy neutrons.
Thermal neutrons follow a Maxwellian distribution in energy, or
11

−𝐸n

ϕ1 (𝐸n ) = 𝑎 𝐸n 𝑒 𝐾B 𝑇

(15)

where a is the magnitude, 𝐾B is Boltzmann constant, and 𝐾B 𝑇 is the most probable kinetic energy, which is equal to 0.025 eV, corresponding to absolute temperature 𝑇 of 293 K.

Figure 2.2. Geometry of a general-purpose proton treatment head and water phantom. Adapted
from Perez-Andujar et al. (2013).
The distribution of 1⁄𝐸 neutrons in energy was modeled as
n

ϕ2 (𝐸n ) =

𝑏
(16)
cnorm(𝐸n , 𝜇2, 𝜎2 ′ ) [1 − cnorm(𝐸n , 𝜇3, 𝜎3 ′ )]
𝐸n

where 𝑏 represents the magnitude and the cumulative normal functions restrict contributions to
the epithermal energy interval, with smooth transitions to neighboring regimes. The parameters

12

for cumulative normal functions restrict 1⁄𝐸 neutron contribution to other energy regimes, spen

cifically below 10−7 MeV and above 1 MeV. These parameters were empirically obtained.
Evaporation neutrons were modeled using a normalized gaussian, or
𝑐

ϕ3 (𝐸n ) =

√2𝜋𝑠

(𝐸 −𝐸̅ )2
−[ n 23 ]
2𝑠
𝑒

(17)

where 𝑐 is the magnitude, 𝐸̅3 is the mean energy of evaporation peak and 𝑠 is the peak width parameter. Equation (15), (16) and (17) represent isotropic emission as discussed earlier.
The cascade neutrons were modeled empirically using three gaussian peaks according to
2

ϕ4 (𝐸n ) =

𝛿
√2𝜋𝑞

+

𝑒

(𝐸n −𝐸̅4,low )
−[
]
2𝑞 2

𝑓(𝜃)
√2𝜋𝑟

−[

2

+

𝑒

𝑒

√2𝜋𝑤

(𝐸n −𝐸̅4,high (𝐸p ))

(18)

2

2𝑟 2

𝑒

(𝐸n −𝐸̅4,med )
−[
]
2𝑤 2

]

where 𝛿, 𝑒, and 𝑓(𝜃) are peak magnitudes, 𝑞, 𝑤, and 𝑟 denote the peak widths and 𝐸̅4,low ,
𝐸̅4,mid , and 𝐸̅4,high (𝐸p ) are the mean energies, respectively. Physically the peaks correspond to
neutrons generated through proton and single nucleon interactions, proton and multiple nucleon
interactions and pre-equilibrium emission.
The mean energy of the highest energy gaussian of the cascade neutron regime,
𝐸̅4,high (𝐸p ), has linear dependence on incident proton energy, as was expected from considerations of relativistic head on collision of nucleons, or
𝐸̅4,high (𝐸p ) = 𝛼p 𝐸p − 𝛽p

(19)

where 𝛼𝑝 and 𝛽𝑝 are empirical fit parameters. Similarly, 𝐸̅4,med was proportional to 𝐸̅4,high (𝐸p )
13

𝐸̅4,med = 𝛾 𝐸̅4,high (𝐸p )

(20)

where 𝛾 is empirical fit parameter. All of the neutrons in the “cascade regime” were modeled
with isotropic emission, except those from nucleon-nucleon collisions (i.e., the last term in Equation (18)), which takes into account the directional dependence of emission of the highest energy
neutrons that are preferentially emitted in the forward cone, or
𝑓(𝜃) = 𝛼f − 𝛽f 𝜃

(21)

where 𝜃 is the angle between the central axis and a ray from the source to the calculation point
𝑝(𝑥, 𝑦, 𝑧) (Figure 2.2), and 𝛼f and 𝛽f are empirical fit parameters.
2.3.2 Neutron Spectral Fluence Data
We used neutron spectral fluence and energy deposition data from simulations of the passive scattering system (Perez-Andujar et al. 2013). These simulations used the Monte Carlo Proton Radiotherapy Treatment Planning (MCPRTP) system (Newhauser et al. 2007), which leverages the Monte Carlo N-Particle eXtended (MCNPX) Radiation Transport Code (Hendricks et
al. 2006). MCNPX is commonly used for simulating neutron exposures and previously has been
extensively benchmarked against measurements (Tayama et al. 2002, Fontenot et al. 2005,
Herault et al. 2005, Tayama et al. 2006, Koch et al. 2008, Farah et al. 2014). Simulations were
performed for an 18 × 18 cm2 field prior to the final collimator, which was fully closed. Neutron
absorbed dose and neutron spectral fluence were tallied in simulations of pristine proton beams
with mean energies at the nozzle entrance of 100, 120, 140, 160, 180, 200, 225, and 250 MeV.
Neutron spectral fluence was tallied in equally spaced logarithmic neutron energy bins (40 bins
per decade). A water phantom of size 30 × 180 × 44 cm3 was used with 100 spherical tally
volumes, each 1cm in diameter. The tally volumes were located along the lines parallel to the
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beam axis at 0 cm, 12 cm, 40 cm, and 80 cm off-axis, as well as one-line perpendicular to the
beam axis at the depth of isocenter in the phantom (22 cm) (see Figure 2.2).
2.3.3 Training of Analytical Model of Neutron Spectral Fluence
We trained our neutron spectral fluence model for the general-purpose beamline at
MDACC, using data from all the tally volumes (Figure 2.2) with proton beam energies of 120
MeV, 140 MeV, 160 MeV, 180 MeV, 200 MeV, 225 MeV and 250 MeV. The 100-MeV spectral
fluence data was not available. The spectral fluence model was fit simultaneously to all 672 simulated neutron spectra using the Marquardt-Levenberg algorithm of (GNUPLOT Version 5.2)
(Williams et al. (2017)) and minimizing weighted sum squared error (WSSR) until a preset criterion (10-5, which was the default value) was met. Simultaneously fitting all spectra allowed direct
and global estimation of all fitting parameters, including parameters that have no explicit dependence on proton energy or position in the phantom. All of the empirical fitting parameters
were selected by minimizing the local relative differences in spectral fluence. The fitting process
took into account the statistical uncertainties in the spectral fluence from Monte Carlo simulations via WSSR. Additionally, the mean energy of the evaporation peak, 𝐸̅3 , and low-energy cascade peak, 𝐸̅4,low , were constrained to be greater than 0.9 MeV based on measured spectra
(Trinkl et al. 2017). Finally, the exponent 𝜏 of the neutron fluence-divergence factor was restricted to be less than 2, which is the maximum physically possible value corresponding to inverse-square divergence from a point source of radiation.
2.3.4 Model Validation
To validate the neutron spectral fluence model (Eq. (10)) we used three separate approaches. First, we integrated it according to
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𝐸max

(22)

Φ = ∫ ϕ(𝐸n ) d𝐸n = ∑ ϕj (𝐸n ) Δ𝐸j
j

0

where ϕj (𝐸n ) is the differential fluence in the jth bin of the neutron spectral fluence and Δ𝐸j is
the width of that bin.
In the second approach, we compared values of the neutron-fluence-weighted mean neutron energy, 𝐸̅n , from MC simulations and analytical model calculations. The mean was calculated using
𝐸max

𝐸̅n =

∫0

ϕ(𝐸n ) 𝐸n 𝑑𝐸n

𝐸max

∫0

ϕ(𝐸n ) d𝐸n

=

∑j ϕj (𝐸n ) 𝐸n Δ𝐸j
∑j 𝜙j (𝐸n ) Δ𝐸j

(23)

where ϕj (𝐸n ) is the differential fluence in the jth bin of the neutron spectral fluence and Δ𝐸j is
the width of that neutron energy bin.
In the third approach we calculated the neutron-fluence-weighted mean neutron kerma
coefficient as
𝐸

𝑘̅ϕ (𝐸n ) =

∫0 max ϕ(𝐸n ) 𝑘ϕ (𝐸n ) d𝐸n
𝐸

∫0 max ϕ(𝐸n ) d𝐸n

=

∑j ϕj (𝐸n ) 𝑘ϕ (𝐸n ) Δ𝐸j

(24)

∑j 𝜙j (𝐸n ) Δ𝐸j

where ϕj (𝐸n ) is the differential fluence in the jth bin of the neutron spectral fluence and Δ𝐸j is
the width of that energy bin. To cross check the calculation of 𝑘̅ϕ (𝐸n ) in Equation (24), we also
calculated it as
̅n)
𝑘̅ϕ (𝐸n ) = 𝑘ϕ (𝐸

where 𝐸̅n was taken from Equation (23).
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(25)

2.4 Kerma Calculation
Using the kerma coefficient model and neutron spectral fluence model, kerma at a point
was calculated using Equation (5). To cross check this result, we calculated kerma as
̅n)
𝐾 = Φ 𝑘ϕ (𝐸

(26)

where Φ is the fluence from Equation (22).

2.5 Absorbed-Dose Calculation
2.5.1 Kerma-to-Absorbed-Dose Conversion Factor
Kerma and absorbed dose are two different physical quantities that are related but not numerically equal, except where CPE exists. Thus, in general a conversion factor, 𝐹𝐾→𝐷 , is needed
to transform kerma to absorbed dose. This conversion factor is given by
𝐷MC = 𝐹𝐾→𝐷 𝐾MC
𝐹𝐾→𝐷 =
=

=

𝐷MC
𝐾MC
𝐷MC
𝐸max
MC (𝐸 ) d𝐸
ϕ(𝐸n ) 𝑘ϕ
∫0
n
n

𝐸

𝐷MC
𝐸

∫0 max ϕ(𝐸n ) 𝑘ϕICRU (𝐸n ) d𝐸n

×

∫0 max ϕ(𝐸n ) 𝑘ϕICRU (𝐸n ) d𝐸n

(27)

𝐸

MC (𝐸 )
∫0 max ϕ(𝐸n ) 𝑘ϕ
n d𝐸n

If we assume equivalence of 𝑘ϕICRU (𝐸n ) and 𝑘ϕMC (𝐸n ), the second term in equation becomes
equal to 1, yielding

𝐹𝐾→𝐷 =

𝐷MC
𝐸
∫0 max ϕ(𝐸n )

where, 𝐷MC is dose from MC simulations.
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ICRU (𝐸 )
𝑘ϕ
n

(28)
d𝐸n

2.5.2 Surface Correction Factor
To account for interface effects near the surface of the phantom, we used an empirical
shallow-depth correction factor given by,
𝐹S = {

𝛼s (1 − 𝑒 −𝜇s 𝑧 )
1

𝑥 ≤ 40 cm
𝑥 > 40 cm

(29)

where 𝛼s , 𝜇s are fit parameters, x is off axis distance and z is depth in water.
Finally, with inclusion of kerma-to-absorbed-dose conversion factor and surface-correction factor the absorbed dose is given by
𝐷AM = 𝐹S 𝐹𝐾→𝐷 𝐾𝐴𝑀

where 𝐾AM is kerma calculated using Equation (6).
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(30)

Chapter 3. Results
3.1 Empirical Model of Kerma Coefficient
Table 3.1 lists the parameters for the analytical model for neutron kerma coefficients (Eq.
9) for the materials listed in table C.3 in ICRU Report 63 (2000). The model was in excellent
agreement over the energy interval from 2.53 × 10−8 MeV to 150 MeV for water with average
1.20% relative difference. Figure 3.1 shows agreement between our model and evaluated ICRU
data for neutron kerma coefficients in water. Further this model was in good agreement for other
materials with average relative difference within 6% as illustrated in Table 3.2.
Table 3.1. Parameters from fitting neutron kerma coefficient values to proposed analytical model
[Eq. (9)].

𝑎1
𝑏1
μ1
σ1 ′
𝑣
𝑢 (10−4 )
2
2
(fGy m )
(fGym MeV) (MeV) (MeV) (fGym2 MeV −2 ) (fGy m2 )
A150 Plastic 2.697 × 10−5
59.25
3.333 1.754
2.754
7.622
−7
Water
4.645 × 10
43.30
2.705 1.571
2.377
7.402
Muscle
46.49
2.911 1.627
2.491
7.140
2.731 × 10−5
−5
Bone
82.57
4.285 1.943
2.706
5.738
2.112 × 10
−5
TE − Meth 2.412 × 10
53.71
3.114 1.690
2.628
7.387
TE − Prop 2.395 × 10−5
53.98
3.163 1.685
2.641
7.307
Material

Note: All significant digits provided should be used to calculate kerma coefficient values and
threshold energy, 𝐸n,Thresh , of 23 MeV was used for all materials.
Higher energy neutrons contributes the majority of kerma because of larger fluence and
kerma coefficient values at higher energies. Since the ICRU tabulated data ranges from thermal
energies up to 150 MeV, extrapolation was used beyond that energy as shown in Figure 3.1.
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Figure 3.1. Neutron kerma coefficient 𝑘ϕ (𝐸n ) versus neutron energy, 𝐸n , in water. Data are from
ICRU Report 63 (points) and the analytical model [Eq. (9)] (line). The absolute difference between kerma coefficient, ∆𝑘ϕ (𝐸n ), are also plotted (right ordinate).

Table 3.2. Average and maximum relative difference in neutron kerma coefficients between data
from ICRU Report 63 and the analytical model over energy range from 2.53 × 10−8 MeV to
150 MeV [Eq. (9)].

Material

Average
Difference
(%)

(%)

A150 Plastic
Water
Muscle
TE − Methane
TE − Propane
Bone

5.110
1.200
5.110
5.800
3.630
2.400

104.32
35.76
53.42
81.67
84.05
93.61
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Maximum
Difference

3.2 Analytical Model of Neutron Spectral Fluence
3.2.1 Parameter Values
Table 3.3 lists the parameters of the analytical model that govern the ϕi (𝐸n ) in Equations (15) to (18), 𝐴𝐹i in Equation (13) and 𝑂𝐴𝐹i in Equation (14). The parameters governing energy scaling (Eq. 11) are in Table 3.4. These parameters were used to evaluate Equation (10) to
calculate neutron spectral fluences. As expected, the effective gaussian width parameters of
OAF’s for the low energy neutron regimes, epithermal and thermal, are large corresponding to
isotropic distribution whereas it is small for cascade neutrons because of their emission in the
forward direction. The exponent, 𝜏, governing divergence of neutron fluence was found to be
1.013. Figure 3.2 plots spectral fluence at isocenter, demonstrating how it varies with proton
beam energy.

Figure 3.2. Selected examples of neutron spectral fluence at isocenter produced by 120 to 250MeV proton beams. These were calculated using the analytical model [Eq. (10)].
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Table 3.3. Parameters governing neutron spectral fluence, ϕi (𝐸n ) [Eq. (15-18)], neutron attenuation factor, 𝐴𝐹i [Eq. (13)] and off-axis factor, 𝑂𝐴𝐹i [Eq. (14)]

Neutron Energy Regime
Thermal

1⁄
𝐸n

Evaporation

Cascade

Parameter
𝑎
𝛼1
𝜎1
𝑏
𝜇2
𝜎2 ′
𝜇3
𝜎3 ′
𝛼2
𝜎2
𝑐
𝑠
̅
𝐸3
𝛼3
𝜎3
𝑑
𝑒
̅
𝐸4,low
𝛾
𝑞
𝑤
𝑟
𝛼f
𝛽f
𝛼p
𝛽p
𝛼4
𝜎4

Value
2.04 × 1010
0.036
85.85
1.07 × 10−7
10−7
3.3 × 10−8
1.0
0.5
0.033
86.51
1.1 × 10−7
2.81
0.9
0.013
16.11
1.88 × 10−6
4.71 × 10−7
1.01
0.78
18.26
18.78
29.41
1.67 × 10−6
1.23 × 10−8
0.93
82.70
0.013
44.42

Units
cm MeV −1
cm−1
cm
−2
cm MeV
MeV
MeV
MeV
MeV
cm−1
cm
cm−2 MeV
MeV
MeV
cm−1
cm
−2
cm MeV
cm−2 MeV
MeV
−
MeV
MeV
MeV
cm−2 MeV
cm−2 MeV
−
MeV
cm−1
cm
−2

Table 3.4. Parameters for modeling dependence of neutron spectral fluence on proton beam energy, as defined in Equation (11).

Parameter Value Units
αE
6704.46
−
ξ
2.53
−
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Figure 3.3 and 3.4 are illustrative examples of how well the analytical model reproduced
neutron spectral fluence data from MC simulations.

22-cm depth

40-cm depth

Figure 3.3. Selected examples of neutron spectral fluence at 22-cm and 40-cm water depth along
central axis produced by 180-MeV proton beams. Green lines with error bars represent data from
Monte Carlo simulations and purple lines are from the analytical model.
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Figure 3.4. Selected examples of neutron spectral fluence at 22-cm and 40-cm water depth along
80 cm off-axis distance produced by 180-MeV proton beams. Green lines with error bars represent data from Monte Carlo simulations and purple lines are from the analytical model.
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Figure 3.4 shows how well our model agrees with MC data at 22 cm (isocentric depth)
and 40 cm along central axis. Figure 3.5 illustrates the agreement between analytical model and
Monte Carlo data in predicting kerma contribution. As expected, kerma is predominated by from
high energy cascade neutrons.

Figure 3.5. Predication of kerma contribution from Monte Carlo (red) and analytical model
(blue) versus neutron energy at 25-cm water depth along central axis for 180-MeV proton beam.

3.2.1 Comparison of Neutron Fluence from Monte Carlo Simulation and Analytical Model
Figure 3.6 plots predictions of fluence from Monte Carlo and analytical models for 120MeV, 180-MeV and 250-MeV proton beams in water. Figure 3.6 (a) shows the fluence variation
with water depth along central axis, while Figure 3.6 (b) shows the corresponding result at 12 cm
off-axis distance. Both figures demonstrate generally good agreement beyond approximately 7cm water depth. Figure 3.7 plots lateral distribution of fluence at 22-cm water depth.
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Figure 3.6. Selected example predictions from Monte Carlo (points) and analytical model (lines) of
neutron fluence Φ versus depth z in water at (a) central axis, (b) 12-cm off-axis distance for 120MeV, 180-MeV and 250-MeV proton beams.
.

Figure 3.7. Selected example predictions from Monte Carlo (points) and analytical model (lines)
of neutron fluence versus off-axis position at 22-cm depth in water for 120-MeV, 180-MeV and
250-MeV proton beams.
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Since our analytical model of neutron spectral fluence doesn’t account the loss of neutrons from the surface of the water phantom, we observed the largest disagreement at shallow
depths, close to the surface, where we overestimated the fluence. The analytical model prediction
of fluence is in reasonable agreement with MC data along the profile at 22 cm depth. The largest
differences were observed at 40-cm off-axis distance in this case.
3.2.3 Fluence-Weighted Average Neutron Energy and Average Neutron Kerma Coefficient
Table 3.5 lists the neutron fluence-weighted average energy and neutron fluenceweighted average kerma coefficient values for selected locations for a 180-MeV proton beam,
including relative differences. There is relatively good agreement between MC calculated values
and analytical model except at shallower depths and far off-axis locations. The agreement was
observed to improve with depth.
Table 3.5. Fluence-weighted average neutron energy, 𝐸̅n , [Eq. (23)] and fluence-weighted average kerma coefficient, 𝑘̅ϕ , [Eq. (24)] including relative difference for 180-MeV proton beams
from analytical model (AM) calculations and Monte Carlo simulations (MC) at selected locations in a water phantom.

Location
𝐸̅n
𝑘̅ϕ
(x, y, z)
AM − MC
AM − MC
AM
MC
AM
MC
(%)
(%)
2
2
(cm, cm, cm) (MeV) (MeV)
(fGy m ) (fGy m )
MC
MC
(0,0,13)
9.68
7.97
21.45
1.62
1.50
8.00
(0,0,22)
21.43 18.81
13.92
3.22
2.94
9.52
(0,0,43)
38.73 46.15
−16.07
5.54
6.31
−12.20
(12,0,13)
8.38
6.77
23.78
1.34
1.38
−2.89
(12,0,22)
18.74 17.25
8.63
2.83
2.80
1.07
(12,0,43)
34.16 44.53
−23.28
4.95
6.19
−20.03
(40,0,13)
8.13
4.65
74.83
1.24
1.03
20.38
(40,0,22)
21.30 14.10
51.06
3.16
2.50
26.45
(40,0,43)
36.31 42.94
−15.44
5.29
6.11
−13.42
(80,0,13)
2.49
5.7
−56.31
0.41
1.12
−63.39
(80,0,22)
20.97 16.26
28.96
3.21
2.81
14.23
(80,0,43)
40.27 36.49
10.35
5.99
5.48
9.31
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Table 3.6 lists the average and maximum relative differences between the 𝐸̅n values calculated with Monte Carlo simulations and those predicted by the analytical model. Consistent
with our findings from fluence calculations, the largest differences are associated with tallies at
shallow water depths and large off-axis distance.
Figure 3.8 plots the variation of fluence-weighted mean neutron energy with off-axis distance and depth for 120-MeV, 180-MeV, and 250-MeV proton beams. Average neutron energy
increases with depth and reaches a maximum value and then decreases gradually. The average
neutron energy decreases gradually with off axis distance and then increases. Further, average
neutron energy also increases monotonically with incident proton energy.
̅̅̅̅̅
̅n , and maximum relative difference,
Table 3.6. Average relative difference, ∆𝐸
̅
̅
∆𝐸n |Max , between 𝐸n values calculated by Monte Carlo method and analytical model [Eq. (23)].

𝐸p
(MeV)
250
225
200
180
160
140
120

∆𝐸̅n |Max
(%)
−99
−98
−99
−94
−99
−99
−160

̅̅̅̅̅
̅n
∆𝐸
(%)
16
19
20
21
23
23
18

Location of
∆𝐸̅n |Max
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,43)

Table 3.7 lists the average and maximum relative differences between the 𝑘̅ϕ values calculated with Monte Carlo simulations and the analytical model for all the energies considered.
Consistent with our findings from fluence calculations and average energy comparison, the largest differences were observed at shallow water depths and at large off-axis distance.
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Figure 3.8. Variation of average neutron energy with off-axis distance and depth for 120-MeV,
180-MeV and 250-Mev proton beam.
Table 3.7. Average relative difference, ̅̅̅̅̅
∆𝑘̅ϕ , and maximum relative difference,
∆𝑘̅ϕ |Max , between 𝑘̅ϕ values calculated by Monte Carlo method [Eq. (24)] and analytical model
[Eq. (25)].
𝐸p
(MeV)
250
225
200
180
160
140
120

∆𝑘̅ϕ |Max
(%)
−150
−98
−97
98
97
98
−150

̅̅̅̅̅
∆𝑘̅ϕ
(%)
29
29
28
25
15
19
11

Location of
∆𝑘̅ϕ |Max
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,1)
(80,0,43)

3.3 Neutron Kerma Calculation
Table 3.8 lists the neutron kerma values calculated at select locations using both MC data
[Eq. (26)] and the analytical model [Eq. (5)] for 120-MeV and 250-MeV proton beams. These
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exhibit reasonably good agreement except at shallow depths and large off-axis distance. Figure
3.9 plots the variation of kerma calculated based on Monte Carlo simulation and our analytical
model at 22-cm water depth for 120-MeV, 180-MeV and 250-MeV proton beams. Consistent
with previous results we see that our model predicts kerma with relatively good accuracy near
the central axis but overpredicts the fluence at 40-cm off-axis distance.
Table 3.8. Select examples of neutron kerma and relative difference for 120-MeV and 250-MeV
proton beams from analytical model (AM) [Eq. (5)] and Monte Carlo simulations (MC) using
[Eq. (26)].

Location
𝐸p = 250 MeV
(x,y,z)
𝐾AM
𝐾MC
(cm, cm, cm)
(Gy)
(Gy)
−16
(0,0,22)
9.37 × 10
9.22 × 10−16
(12,0,22)
8.77 × 10−16 7.30 × 10−16
(40,0,22)
5.35 × 10−16 2.11 × 10−16
(80,0,22)
1.15 × 10−16 6.09 × 10−17

𝐸p = 120 MeV
Diff
Diff
𝐾AM
𝐾MC
(%)
(%)
(Gy)
(Gy)
−17
−17
1.6 8.15 × 10
11
7.34 × 10
−17
−17
20 7.37 × 10
29
5.71 × 10
128 3.85 × 10−17 1.27 × 10−17 203
69 8.35 × 10−18 4.11 × 10−18 103

Figure 3.9. Predicted kerma, K, from Monte Carlo (points) and analytical model (lines) of kerma
versus off-axis position, x, at 22-cm depth in a water for 120-MeV, 180-MeV and 250-MeV proton beam.
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3.4 Absorbed-Dose Calculation
3.4.1 Kerma-to-Absorbed Dose Conversion Factor and Surface Correction Factor
Using Eq. (28), we calculated kerma-to-absorbed-dose conversion factor, 𝐹𝐾→𝐷 at all the
tally locations. Figure 3.10 plots variation of absorbed dose reported by MC and kerma calculated using MC data for 180-MeV proton beam with off-axis distance whereas Figure 3.11 plots
𝐹𝐾→𝐷 versus off-axis distance for the same case. Absorbed dose along the profile was found to
be slightly greater than kerma for most locations. The fluctuations in kerma-to-absorbed-dose
conversion factors were averaged and a value of 1.18 was used as conversion factor.

Figure 3.10. Comparison of absorbed-dose, D, and kerma, K, calculated using MC data versus
off-axis distance xfrom a 180-MeV proton beam at 22-cm depth in a water phantom.
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Figure 3.11. Kerma-to-absorbed dose conversion factor, 𝐹𝐾→𝐷 , versus off-axis distance for 180MeV proton beam at 22-cm depth.
The values of the parameters governing the shallow depth correction (Eq. 29) 𝛼s and
𝜇s were empirically found to be 0.72 and 0.2781 cm−1 respectively.
3.4.2 Corrected Absorbed Dose Calculation
We utilized the kerma-to-absorbed-dose conversion factor and surface correction factor
to calculate absorbed dose in water using Equation (30). The absorbed dose from MC simulation
and our model are shown in Figure 3.12, revealing relatively good agreement. Consistent with
our fluence and kerma predictions, our model predicts dose with relatively good accuracy along
central axis and a slight overprediction of absorbed dose near 40 cm off-axis distance.
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Figure 3.12. Predictions of absorbed dose, D, from analytical model (lines) and Monte Carlo calculation (points) versus off-axis distance, x, in water for 120-MeV, 180-MeV and 250-MeV proton beams at 22-cm depth.

Figure 3.13 plots the absorbed dose versus depth along central axis from the MC simulations and analytical model for 120-MeV, 180-MeV and 250-MeV proton beams. The figure reveals good agreement between the MC and analytical model predictions. Table 3.9 lists the aver̅ , and the maximum relative difference, ∆𝐷
̅ |Max , between values. The
age relative difference, ∆𝐷
average relative difference at all the locations in phantom for all energies was about 50%. The
maximum relative differences were observed mostly at 80-cm off-axis distances and at deeper
depths where our model overestimates absorbed dose.
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Figure 3.13. Prediction of absorbed dose, D, from analytical model (lines) and Monte Carlo calculation (points) versus depth in water, z, for 120-MeV, 180-MeV and 250-MeV proton beams.
Table 3.9. Average relative difference, ̅̅̅̅
∆𝐷 , and maximum relative difference, ∆𝐷 |Max , between
absorbed-dose values calculated by Monte Carlo method and the analytical model considering all
the tally volumes in the water phantom.

𝐸p
(MeV)

̅̅̅̅
∆𝐷
(%)

∆𝐷 |Max
(%)

250
225
200
180
160
140
120

52
50
43
52
47
54
92

217
173
187
269
264
263
374
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Location of
∆𝐷 |Max
(x, y, z) cm
(80,0,40)
(80,0,37)
(80,0,27)
(80,0,43)
(80,0,28)
(80,0,37)
(80,0,27)

Chapter 4. Discussion
An analytical model was developed to calculate the neutron spectral fluence, kerma, and
absorbed dose in a water-box phantom for passively scattered proton therapy beams of 120 MeV
to 250 MeV. The model calculates neutron spectral fluence, then applies neutron kerma coefficients to obtain kerma, and finally applies a kerma-to-absorbed dose conversion factor and a surface correction factor. Evidently, it is possible to predict absorbed dose due to stray neutrons
with an analytical approach within reasonable accuracy. Average relative difference observed in
case of neutron spectral fluence, neutron kerma coefficient and absorbed dose were approximately 23%, 6% and 50% respectively.
This model, with some refinements, appears potentially suitable for integration in treatment planning system. Because the model is physics-based, we believe it is generally applicable,
i.e., can be utilized for a variety of treatment systems. The fluence model allows calculation of
kerma and absorbed dose, which are measurable quantities, facilitating validation and calibration. This approach also helps us separately calculate the physical and the biological aspects of
neutron exposures, i.e., it provides a method to calculate absorbed dose, rather than equivalent
dose which takes into account neutron quality, which is challenging in radiation therapy exposures. For these reasons, our model could enable risk calculations in prospective and retrospective cases, providing a potentially powerful tool for designing and conducting epidemiology
studies and clinical trials.
The results from this work are generally consistent with the findings from previous studies. Perez-Andujar et al. (2013) found that analytical models of neutron exposure required 49 parameters to predict equivalent dose. Schneider et al. (2015) subsequently improved the model
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from Perez-Andujar et al. (2013) reducing the required number of parameters to 22. In comparison, our analytical model with just 40 parameters calculates numerous quantities with reasonable
accuracy. Thus, our model is similarly parsimonious but with the capability to predict more
quantities (Φ(𝐸n ), Φn , 𝐾, D), albeit at lower accuracy than that reported by Perez-Andujar et al.
(2013). Recently, Dommert et al. (2017) reported a neutron spectral fluence model but with less
resolution of structure above 1 MeV. The approach of Dommert et al. (2017) requires 11 parameters per spectral fluence whereas our model requires 18 parameters per spectral fluence but has
higher resolution above 1 MeV. The reported model from Dommert et. al. (2017) did not explicitly account for proton beam energy, neutron source position, fluence divergence and attenuation.
In contrast, our neutron spectral fluence model uses 30 parameters and predicts spectra at all the
locations in a water phantom for wide range of energies. Additional, we explicitly modeled
source position, attenuation, source distribution.
This project has several strengths. We used a vast amount of high quality radiometric
data to train our model. Further, our model uses relatively simple physics-based theories, that
provide good explanatory power. Additionally, we modeled the intermediate quantities neutron
spectral fluence and kerma rather than dose equivalent. ϕ(𝐸n ) and 𝐷 can be directly confirmed
by radiation measurements, e.g., in the reference field at a standards laboratory. Being able to
calculate ϕ(𝐸p , 𝑥, 𝑦, 𝑧) gives valuable information about the radiation quality (e.g., mean neutron energy) and allows for material dependence in kerma and absorbed-dose calculations.
A limitation of this work is that physics of radiation transport near the surface of phantom
is more complex than our spectral fluence model takes into account, as evidenced by relatively
poor agreement in some surface regions. Another limitation of the study is that it only uses MC
simulated data, i.e., no measurements were used. This is not a major limitation because the MC
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code was previously benchmarked extensively in the literature. Additionally, we used only a water-box phantom data and thus we have not tested its capabilities in anatomic phantoms. This is
not a serious limitation because the goal of this project is to investigate the feasibility of modeling the underlying transport physics in a simple phantom.
Future work should include study of the physics of neutron transport to improve accuracy
in absorbed dose, especially near the phantom surfaces, extend the energy interval to lower proton beam energies (~ 50 MeV) for ocular treatments. Additional work should focus on implementation in treatment planning system and validation against measurements. Finally, computational speed should be investigated because of the large number of calculation points needed for
whole-body dose assessments.
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Chapter 5. Conclusion
In this work, we developed a physics based analytical model of neutron spectral fluence
and an empirical model of neutron kerma coefficients. We combined these to calculate kerma
and absorbed dose from stray neutrons. An empirical model of neutron kerma coefficient revealed good agreement with evaluated data from the literature upto 150 MeV. The analytical
model for neutron spectral fluence also revealed relatively good agreement with that from MC
data. A study of kerma-to-absorbed-dose conversion factor was also performed which suggested
it can be approximated as a constant.
The results suggest that it is feasible to use the neutron-fluence-based approach to predict
absorbed dose to water from stray neutrons with relatively good accuracy except at shallower
depths and far off-axis locations. The results of this work suggest that, with further development
and testing, it appears potentially conceivable to perform routine absorbed dose calculation of
stray neutron exposure to patients who receive proton beam therapy. A potentially important advantage of this fluence-based approach is that it provides us the ability to take material dependence into account and facilitates characterization of radiation quality of the neutron fields.
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